Article
Excision repair cross-complementation group 1 codon 118 polymorphism, micro ribonucleic acid and protein expression, clinical outcome of the advanced gastric cancer response to first-line FOLFOX-4 in Qinghai-Tibetan plateau population.
Journal of cancer research and therapeutics - 1 Jan 2000
Qi Yu-Juan, Cui Sen, Yang Ying-Zhong, Han Jing-Qi, Cai Bao-Jia, Sheng Cun-Fang, Ma Yan, Wuren Tana, Ge Ri-Li
Abstract excerpt
CONTEXT: The excision repair cross-complementation group 1 (ERCC1) codon 118 C/T polymorphism has been associated with clinical outcome in cancer patients treated with platinum chemotherapy. Ethnic differences in the frequency of this polymorphism have been observed in Caucasian and African populations. AIM: The aim of this study was to evaluate the frequency and survival benefit of the ERCC1 codon 118 C/T...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
